Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "Press release" return 97 results.
Ceva expands oral rabies vaccine portfolio with the acquisition of Canadian firm Artemis Technologies, Inc. >
This strategic acquisition complements Ceva’s rabies portfolio.
Ceva Santé Animale announces Japan-based joint venture with Mitsui >
Promoting Ceva Santé Animale’s image and business strategy in Japan
Annual WVA Global Animal Welfare Awards held during the 37th World Veterinary Association Congress >
The WVA and Ceva Santé Animale are thrilled to continue their collaborations to underline and recognise the work done by outstanding people and institutions to advance animal welfare.
Ceva invests in its European vaccine production capacity to create the EU’s largest cryogenic storage facility in Monor >
The new site is situated in Monor, 40kms from the centre of Budapest.
Research and innovation in animal health: a strengthened partnership between INRAE and Ceva Santé Animale >
A shared commitment to the "One Health" global health concept
Ceva returns to strong double-digit growth in 2019 and reveals plans to double sales by 2025 >
Libourne, 12 March 2020 - Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019 as the company returned to strong double-digit growth (+14.6%). The start of 2020 was marked by t...
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries >
Libourne 8th July 2019 - Pig farmers in 12 European countries will now be able to protect their herds against the growing problem of Salmonella Typhimurium. Ceva will launch Salmoporc in Austria, Belg...
Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split >
Libourne & Dessau 3rd July 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) today announced that they have successfully completed the acquisition of IDT’s veterinary biopharmaceutical...
Ceva Sante Animale makes Laval its global hub for innovation in the companion animal sector >
Laval, 25 June 2019 - Ceva, France’s largest veterinary biopharmaceutical company, has consolidated its investments in Mainland France, specifically in Laval, where it has established its global hub f...
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portf... >
Libourne & Dessau 17th. May 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and...